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Abstract
Mutations in the enzyme superoxide dismutase-1 (SOD1) cause hereditary variants of the fatal motor neuronal disease
Amyotrophic lateral sclerosis (ALS). Pathophysiology of the disease is non-cell-autonomous: neurotoxicity is derived not
only from mutant motor neurons but also from mutant neighbouring non-neuronal cells. In vivo imaging by two-photon
laser-scanning microscopy was used to compare the role of microglia/macrophage-related neuroinflammation in the CNS
and PNS using ALS-linked transgenic SOD1
G93A mice. These mice contained labeled projection neurons and labeled
microglia/macrophages. In the affected lateral spinal cord (in contrast to non-affected dorsal columns), different phases of
microglia-mediated inflammation were observed: highly reactive microglial cells in preclinical stages (in 60-day-old mice the
reaction to axonal transection was ,180% of control) and morphologically transformed microglia that have lost their
function of tissue surveillance and injury-directed response in clinical stages (reaction to axonal transection was lower than
50% of control). Furthermore, unlike CNS microglia, macrophages of the PNS lack any substantial morphological reaction
while preclinical degeneration of peripheral motor axons and neuromuscular junctions was observed. We present in vivo
evidence for a different inflammatory activity of microglia and macrophages: an aberrant neuroinflammatory response of
microglia in the CNS and an apparently mainly neurodegenerative process in the PNS.
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Introduction
Amyotrophic lateral sclerosis (ALS) is an adult-onset neurolog-
ical disorder characterized by progressive loss of upper and lower
motor neurons and degeneration of pyramidal tracts. Transgenic
mice expressing various human ALS-linked mutations in the gene
encoding the enzyme superoxide dismutase-1 (mSOD1) mimic to
some extent the fatal paralysis seen in patients [1,2,3,4,5,6].
Dominant mutations in SOD1 are, so far known, the most
frequent cause of familial ALS (fALS). In addition, the best-studied
animal model of fALS is that caused by mutations in SOD1 [7].
Also in sporadic ALS (sALS), the analysis of the structure of
amyloid fibrils [8] and the presence of misfolded SOD1 in the
spinal cord of sALS patients [9] suggest an involvement of SOD1
in the pathophysiology of the disease. In addition, recent clinical
and electrophysiological data show that the human SOD1-G93A
phenotype closely resembles sALS suggesting comparable disease
pathology [10].
The mSOD1-mediated toxicity is non-cell-autonomous deriving
not only from motor neurons but also from neighbouring glia. In
particular, microglia and astrocytes substantially contribute to
motor neuron death and disease progression [4,5,6,11,12,
13,14,15]. In the case of microglia, selective silencing of the
mutant gene in the innate immune cells of the CNS and in
macrophages in a SOD1-model has substantially slowed disease
progression [4,5]. In addition, replacement of mSOD1-expressing
cells of the myeloid lineage including microglia by non-mutated
cells via bone marrow transplantation equally slowed disease
progression [11]. These studies strongly emphasize a microglial
contribution to the propagation of motor neuron death. Despite
this evidence the impact of neuroinflammation to disease
progression is still a matter of debate and little is known about
the functional state of mSOD1-expressing microglia during disease
progression.
In addition, recent evidence suggests that loss of peripheral
axons and neuromuscular synapses is a primary event in motor
neuron degeneration, even before the respective lower motor
neuron cell bodies show signs of degeneration [16,17]. The impact
of neuroinflammation on axonal degeneration in the peripheral
nervous system is, however, still elusive.
Microglia as the monocyte-lineage immune effector cells of the
CNS play central roles in CNS neuroinflammation. In the resting
state, microglia display highly dynamic process movements to
constantly survey their microenvironment in brain [18,19] and
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to rapidly respond to injuries within nervous tissue [18,19,20,21].
Following acute tissue injury, surrounding microglia extend
processes towards the injured site within minutes while retracting
opposite processes: a phenomenon called polarization. Within a
few hours following subsequent ameboid transformation, respond-
ing microglia begin migrating and commence phagocytosis. This
injury-induced transformation of microglia to reactive states is
known as microglial activation [23].
Here, we used time-lapse 2-photon laser-scanning microscopy
(2P-LSM) and transgenic mouse technology to investigate
microglia and macrophage reaction during disease course in the
SOD1-G93A (SOD1
G93A) mouse model for ALS. The use of
transgenic mice containing both fluorescent microglia/macro-
phages [24] and neurons [25] enables us to correlate mutation-
induced changes of microglia/macrophage function with the
progressive axonal degeneration in the CNS or PNS, respectively.
Since the stages of microglial activation are in part defined by their
response to injury, including polarization, migration and phago-
cytosis [23], we also investigated the reaction of microglia to
axonal transection in different stages of SOD1
G93A mice. In a
second approach, the microglia-related macrophages of the PNS
were investigated using the same paradigms. The in vivo imaging
approach allows us to combine morphological changes with
cellular behavior in an intact environment under baseline
conditions as well as in response to focal lesions. Since the
maintenance and local expansion of mSOD1-microglia is
dependent on self-renewal within the CNS, we refer to microglia
as the resident monocyte-lineage cells of the CNS [26].
CNS microglia showed substantial inflammatory activity. In
preclinical stages, microglial cells that highly reacted towards focal
lesions acquired over the course of the disease an ameboid shape
indicating morphological transformation and consequent cellular
activation. In clinical stages activated microglia lost their injury-
directed response. In contrast to microglia-mediated neuroin-
flammation in the CNS, morphologically pro-inflammatory
reactions of macrophages were negligible in the PNS suggesting
primarily passive roles of macrophages in axonal degeneration.
Materials and Methods
Ethics statement
The experiments were performed according to the ethical
guidelines of the national animal protection law and were
authorized by the ethical committee of the State of Lower Saxony
(review board institution: Niedersa ¨chsisches Landesamt fu ¨r
Verbraucherschutz und Lebensmittelsicherheit, Dezernat 33,
Oldenburg, Germany; approval-ID: 509.42502/01-39.03).
Mouse strains
Transgenic TgN(SOD1-G93A)G1H mice (The Jackson Labo-
ratory, Bar Harbor, USA) were maintained as hemizygotes by
mating transgenic males with B6SJL hybrid females. Hemizygote
male TgN(SOD1-G93A)G1H mice were crossbred with
female TgH(CX3CR1-EGFP)xTgN(THY1-EYFP) mice to obtain
SOD1
G93A mice with fluorescently labeled macrophages/microg-
lia and projection neurons. TgH(CX3CR1-EGFP)xTgN(THY1-
EYFP) mice were previously obtained by crossbreeding homozy-
gous CX3CR1-EGFP mice, in which the expression of the green
fluorescent protein EGFP in monocytes, macrophages and
microglia is achieved by placement of the EGFP reporter gene
into the Cx3cr1 locus encoding the chemokine receptor CX3CR1
[24], with transgenic THY1-EYFP mice expressing the yellow
fluorescent protein EYFP in projection neurons and their
respective axons [27]. TgH(CX3CR1-EGFP) mice and
TgN(THY1-EYFP) mice were of B6SJL background for more
than 10 generations. The corresponding littermates (hemizygotes
with respect to all three genetic alterations) were used to study
microglia-axon interactions in vivo during the disease course of
SOD1
G93A by discerning their cell-type specific fluorescent protein
expression simultaneously.
The experiments were carried out on adult mutant mice
(preclinical: 60 and 75-day-old; onset of disease: 90-day-old;
clinical: 105 and advanced clinical: 120-day-old). Non-transgenic
littermates were used as controls. In control mice, no age-related
changes in microglial behavior were observed. Even though
female SOD1
G93A expressing mice survive a few days longer than
male mutant mice, gender-dependent differences in microglial
morphology and reactions were not observed. Similarly, there
were no gender-dependent differences in the behavior of
macrophages in the PNS. Mice were kept in the mouse facility
of the institute according to national and European guidelines for
the welfare of experimental animals.
Immunohistochemistry
The animals were anesthetized (80 mg pentobarbital sodium per
kg body weight i. p.) and perfused transcardially with PBS followed
by 4% paraformaldehyde. After tissue processing, 20 mm-thick
cryosections were cut from the lumbar spinal cord. After thawing
and rehydration, the sections were incubated with blocking buffer
(10% normal goat serum and 0.1% Triton X-100) followed by
primary antibody (SMI32, 1:1000; purchased from Sternberger
Monoclonal Incorporated, Lutherville, USA). Samples were
incubated with a fluorescent Cy-3 conjugated secondary antibody
(1:500; Jackson Immunoresearch, West Grove, PA, USA).
Confocal images were obtained using a Zeiss Axiovert 200M/
LSM 510 Meta confocal laser-scanning microscope (Zeiss, Jena,
Germany) equipped with argon (488 nm) and HeNe (543 nm)
laser.
Anesthesia and surgery
The experiments were carried out on mice of different clinical
stages of SOD1
G93A and on control mice of corresponding age (60
to 140 days of age) under general anesthesia initiated by 80 mg
pentobarbital sodium i. p. (dissolved in 0.9% NaCl) per kg body
weight. After cannulation of the jugular vein, anesthesia was
continued with 40-60 mg per kg and h methohexital sodium
(Brevimytal, Hikma, London, UK). A tracheotomy was performed
and a tracheal tube was inserted for artificial ventilation. Spinal
cord segments L4 and L5 were exposed by laminectomy of the
spines L1 to L3 for image recording of the dorsal column.
Recording of the lateral column was achieved by turning the mice
by 80 degrees. To avoid movement caused by active respiration
during imaging, the animal was paralyzed with pancuronium
bromide (Pancuronium Organon, Essex Pharma GmbH, Munich,
Germany; 800 mg per kg and h by i. p. injection every hour) and
artificially ventilated with a gas mixture of CO2 (2.5%), O2
(47.5%), and N2 (50%) at 120 strokes/min (100-160 ml/stroke
depending on the body weight). In addition, spinal column was
rigidly fixed with two custom-made clamps, each having two joints
for keeping the mouse in the turned position.
For exposing proximal peripheral nervous tissue including
spinal roots and dorsal ganglia, the dura was carefully removed
without setting a lesion to the spinal cord. In all experiments, the
exposed spinal cord was continuously superfused with ACSF
(artificial cerebro-spinal fluid: 125 mM NaCl, 25 mM NaHCO3,
2.5 mM KCl, 1.25 KH2PO4, 1 mM MgCl2, 2 mM CaCl2*H2O
and 10 mM glucose). For recordings of peripheral nerves and
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were exposed, respectively. For this purpose, spinal column and
the respective foot, each, were fixed with a clamp. For labeling of
blood vessels, we injected Texas Red-Dextran (70 kDa, 1.25% w/
v, Invitrogen) through a second central venous catheter after
cannulation of the other jugular vein. After an initial injection of
50 ml bolus (5 min. before the start of the experiment), application
of Texas Red was continued with 50 ml per hour. Rectal body
temperature was measured and kept between 36 and 38uCb ya
heated plate. Electrocardiograms were monitored throughout the
experiment. A heart rate below 420 per min was taken as sign for
sufficient anesthesia [20,21]. Furthermore, the dose of methohex-
ital used in pancuronium-paralyzed mice was the same dose we
previously used in non-paralyzed mice with corresponding weight.
The depth of anesthesia was tested by provoking the corneal reflex
and reactions to noxious stimuli.
2-Photon laser-scanning microscopy and image
acquisition
Photographic and epifluorescence overviews of the spinal cord
were acquired using a 56(NA 0.15) objective (Carl Zeiss GmbH,
Jena, Germany) and a CCD camera. High resolution in vivo
imaging was performed using a commercial two-photon laser-
scanning microscope (2P-LSM, Zeiss Axiocope 2 with LSM510
NLO scanhead) equipped with a fs-pulsed, mode-locked titanium-
sapphire infrared laser (Mira 900/10 W Verdi; Coherent,
Glasgow, UK) or a custom-made 2P-LSM equipped with a fs-
pulsed titanium-sapphire laser (Chameleon Ultra II; Coherent).
For 2P-recordings, a Zeiss W N-Achroplan 406 (NA 0.75) or a
Zeiss W Plan Apochromat 206 (NA 1.0) water immersion
objective was used. For excitation, the laser was set at
89565 nm for the simultaneous excitation of EGFP and EYFP.
Emitted light was split by a 520 nm longpass dichroic mirror
(Semrock, Rochester, USA) and collected by photo-multiplier
tubes (Hamamatsu, Japan) through two bandpass filters: a
494620.5 nm (FF01-494/41-25) and a 542625 nm (FF01-542/
50-25 (Semrock). The fluorescence of Texas Red was separated
from the EGFP or EYFP signal by a 560 nm long pass filter (Carl
Zeiss) and a HQ575 emission filter (AHF Analysentechnik,
Tu ¨bingen, Germany). The relations of the measured fluorescence
intensities were comparable between the two microscopes.
Parallel, uniformly spaced (1.5 to 2.4 mm) planes of 100*100 to
600*600 mm
2 regions were recorded, digitized and processed to
obtain z-stacks of images (2566256 to 102461024 pixels in size).
Voxel sizes ranged from 0.260.261.5 to 1.1761.1762.4 mm for
the xyz-axes. The total acquisition time for a stack of 15 to 30
images was approximately 1-2 min. Recordings of, at most,
100 mm stack depth were obtained. Several stacks were taken
continuously to get time-lapse series of microglial action.
Standardized lesions were applied by the titanium-sapphire laser
focused for 2 seconds to a plane of an axon diameter until the
fluorescence signal began increasing. Only morphologically intact
axons were chosen for the experiments.
Image processing and morphometric analysis
Image processing and morphometric analysis were performed
using the Zeiss LSM software, ImageJ (http://rsbweb.nih.gov/ij)
and Matlab (version 7, MathWorks, Ismaning, Germany).
Statistical analysis was performed using Origin 7 software
(Northampton, USA). Prior to any analysis, the time series of
image stacks were corrected for the shifts in the horizontal and
vertical directions by using an autocorrelation based on custom-
made software written in Matlab (v.7). In the majority of images,
detector noise was removed by the median filter of ImageJ. The
recorded stacks are shown in maximum intensity projections
(MIPs). Although EGFP and EYFP signals cannot be separated
without spectral unmixing, the filter sets were chosen in a way that
permitted an unambiguous distinction of EGFP expressing
microglia from EYFP expressing neurons. The cellular differen-
tiation was facilitated by the different morphologies of axons and
microglia and the large predominance of EGFP signal in one
channel. Decrease and increase of axonal and microglial
fluorescence signals, respectively, was measured by area fraction
analysis (ImageJ) of particles in comparable regions using the
corresponding channels. Prior to that, proper precautions were
taken to ensure that respective fluorescence signals were similar in
different control mice or in different SOD1
G93A mice of the same
stage. The number of axons in comparable regions was measured
by plot profile analysis (ImageJ). Ramification analysis referred to
the main processes directly originating from the microglial cell
body [20]. To determine the motility of microglial processes,
changes of the length of microglial processes were determined in
relation to the control situation before lesion and after laser-
induced injury. The outermost processes comprising protrusions at
their end were quantified. Measurements of the intracellular area
of single macrophages in MIPs were performed using Zeiss LSM
software. Care was taken to avoid measurements of multiple cells,
e. g. no measurements were performed in macrophage cell
clusters. With regard to ramification analysis and to measurements
of the intracellular area, at least three exemplary cells were
analyzed per mouse. For quantification purposes, we defined
increases in fluorescence located directly around the injured site as
the microglial response [18,20]. Increases in fluorescence attrib-
uted to process ingrowth or soma migration were not distin-
guished. We used the function R(t)=(Rx(t) 2 Rx(0))/Ry(0) as
described [18]. For this purpose, we used the Analyze Particle
function of ImageJ to measure the microglial density around an
injury. Diameters for outer (y) and inner (x) area were 70 mm and
35 mm, respectively. We included only comparable lesions in the
analysis, indicated by the average size of the autofluorescence
signal. The rate of engulfments was equally measured in
comparable regions (MIPs; xy-size about 250x250 mm
2) in four
preclinical, four clinical mice and four controls.
Statistical analysis
For statistical analysis Origin 7 software (Northampton, USA)
was used. Mean values were given 6 standard of the mean (SEM).
Statistical significance (p,0.05) was determined using ANOVA
followed by Tukey test.
Results
In vivo 2P-LSM was applied to simultaneously record central
axons of projection neurons and microglia in the spinal cord
[20,21]. In a second approach, lower motor axons and
macrophages in spinal roots, peripheral nerves as well as
neuromuscular junctions were investigated.
Axon degeneration and microglia activation in lateral
spinal cord of SOD1
G93A
Under general anesthesia and after exposure of the spinal cord
segments L4 and L5 by laminectomy of the spines L1 to L3, a
laser-induced lesion was set to the lateral column of the spinal cord
(Fig. 1A). Using this approach, we were able to record a part of the
spinal cord under in vivo conditions which largely carries out
efferent, i. e. motor functions.
In rodents, different from the human anatomy, axons of the
corticospinal tract (CST) are located in both the deep part of the
Central & Peripheral Inflammation in ALS
PLoS ONE | www.plosone.org 3 March 2011 | Volume 6 | Issue 3 | e17910dorsal column as well as the lateral column of the spinal cord.
Affected upper motor axons are predominantly observed in the
lateral column of mSOD1 mice [28]. Here, mainly descending
axons including approximately 20% of all CST axons are located.
Additionally, early vascular changes leading to neurotoxic
microhemorrhages, indicated by hemosiderin deposits, exist to
a greater extent in the lateral white matter of the spinal cord than
in the dorsal or ventral white matter [29]. A high number of
degenerated, interrupted and swollen axons were found in the
lateral column of the lumbar spinal cord in clinically affected
SOD1
G93A compared to preclinical animals (Fig. 1B). Accord-
ingly, signal density of EYFP-labeled axons in comparable
regions was reduced during disease course from preclinical 60-
day-old mice (set as 10066.6%, n=6 mice) to 90-day-old (onset
of disease, 68.968.6%, n=6, p,0.05) and to 120-day-old
animals (advanced clinical stage, 41.265.9%, n=6, p,0.001)
(Fig. 1C). The signal density in 60-day-old mice was comparable
to that in control mice (10162.6%, n=8) (Fig. 1C). The number
of axons in comparable regions was also reduced during the
disease course from 60-day-old mice (set as 100611.9%, n=5
mice) to 90-day-old (44.365.5%, n=4, p,0.01) and to 120-day-
old mice (25.962%, n=5, p,0.001). The number of axons in
60-day-old mice was comparable to that in control mice
(102.567%, n=6).
Figure 1. Axonal degeneration and microglial activation in the lateral column of the spinal cord. Spinal cord microglia cells were
recorded, shown in part with neighbouring axons, within the lateral column during the disease course of SOD1
G93A. The experiments were performed
in double transgenic mice expressing EGFP in microglia and EYFP in projection neurons. For better visualization, EYFP fluorescence is depicted with a
red color table in all images. All two-photon images are arranged such that rostral is to the left side. A, confocal image of a SMI32-stained cross
section of spinal cord. Motor neurons were stained in the ventral part of the lumbar spinal cord. The autofluorescence of a lesion (arrow) induced by a
two-photon laser pulse before perfusion of the mouse indicates the area of in vivo imaging in the lateral column of the spinal cord. B, Time course of
axonal degeneration in SOD1
G93A mice. Recordings were obtained in preclinical (75-day-old) and advanced clinical (120-day-old) stages in
comparable regions of the lateral spinal cord. In 120-day-old mutant mice axons were mostly swollen and interrupted (some exemplary axons are
marked by arrows). Note the green fluorescence of monocytes inside the vessels (vessel boundaries marked by arrowheads). C,D, Quantification of
axonal and microglial signal density, respectively, in comparable regions of the lateral spinal cord during the course of disease from preclinical stage
(60-day-old), onset of disease (90-day-old) to advanced clinical stage (120-day-old). E, Continuous change of microglial morphology towards a more
ovoid and a less ramified shape from preclinical stages (60-day-old and 75-day-old), onset of disease (90-day-old) to clinical and advanced clinical
stages (105-day-old and 120-day-old). F,G, Quantification of microglial ramification and process motility during the same stages of disease as shown
in E. H, An exemplary microglia cell cluster is depicted in a clinical stage (105-day-old). Values are presented as mean 6 SEM; statistical significance
determined by using ANOVA followed by Tukey test (*p,0.05, **p,0.01, ***p,0.001). GM, grey matter; WM, white matter; DC, dorsal column; LC,
lateral column; DR, dorsal root; VR, ventral root.
doi:10.1371/journal.pone.0017910.g001
Central & Peripheral Inflammation in ALS
PLoS ONE | www.plosone.org 4 March 2011 | Volume 6 | Issue 3 | e17910Coinciding with axonal degeneration, signal density of EGFP-
labeled microglia in the respective areas significantly increased
with the age of the mouse from 60-day-old (set as 100610.8%,
n=6 mice) to 90-day-old (102.5611.6%, n=6) to 120-day-old
animals (141.7615.5%, n=6, p,0.05) (Fig. 1D). The signal
density in 60-day-old mice was comparable to that in control mice
(100.269.6%, n=8; Fig. 1D). As shown previously in Iba1- and
CD11b-stained lumbar tissue, the number of activated microglia
increases during disease progression [4]. Furthermore, a substan-
tial increase in the number of activated microglia is observed in the
ventral horn of the lumbar spinal cord in clinical stages indicated
by MHCII-staining [30]. In support with these earlier studies, the
number of EGFP-labeled microglia in the respective areas
significantly increased with the age of transgenic mice from 60-
day-old (set as 10069.4%, n=5 mice) to 90-day-old
(118.367.6%, n=4) and to 120-day-old animals (173.3624.7%,
n=5, p,0.05). The number of microglia in 60-day-old mice was
comparable to that in control mice (97.7612.5%, n=6).
During the course of the SOD1
G93A disease, microglial cells in
the spinal cord lateral column underwent a continuous change of
their morphology towards an ameboid-like shape, indicating
ongoing inflammatory activity (Fig. 1E). The number of microglial
processes extending from the cell soma (so-called first order
processes) continuously decreased from preclinical stages (60-day-
old: 4.5560.3, n=15 cells in 5 mice; 75-day-old: 4.2260.22,
n=12 in 4 mice) and onset of disease (90-day-old: 4.2360.35,
n=18 in 6 mice) to clinical stages (105-day-old: 3.1860.19, n=23
in 6 mice, p,0.01; 120-day-old: 2.7860.21, n=32 cells in 8 mice,
p,0.001) (Fig. 1F). The number of first order processes of
preclinical microglia was comparable to that of control microglia
(4.7160.46, n=16 in 6 mice) (Fig. 1F).
In addition, baseline motility of microglial processes slowed by
nearly 50% in the same time course (60-day-old mice:
1.8360.19 mm/min, n=36 microglial processes in 5 mice; 75-
day-old: 1.6360.25 mm/min, n=26 in 4 mice; 90-day-old:
1.8660.23 mm/min, n=41 in 6 mice; 105-day-old: 1.296
0.19 mm/min, n=41 in 6 mice, p,0.05; 120-day-old: 0.96
0.11 mm/min, n=45 in 8 mice, p,0.01) (Fig. 1G). Microglial
processes of 60-day-old to 90-day-old mice displayed comparable
baseline motility to processes of control microglia (2.2660.44,
n=33 in 6 mice). Process retractions similarly slowed during the
disease course (control: 22.2560.39, n=33 in 6 mice; 60-day-old
mice: 21.8860.14 mm/min, n=36 in 5 mice; 75-day-old:
21.7160.25 mm/min, n=26 in 4 mice; 90-day-old: 21.826
0.2 mm/min, n=41 in 6 mice; 105-day-old: 21.3360.16 mm/
min, n=41 in 6 mice, p,0.05; 120-day-old: 2160.08 mm/min,
n=45 in 8 mice, p,0.001).
Unlike WT-microglia, which mutually repel each other when
neighbouring cells encounter one another [19], mutant microglia
formed cell clusters in clinical stages of SOD1
G93A (Fig. 1H).
Highly reactive preclinical SOD1
G93A microglia lose their
target-directed response in clinical stages
In the next set of experiments, we analyzed the microglial
response towards laser-mediated axonal injury during disease
course. In Fig. 2A, the microglial reaction towards a single axon
transection in the spinal lateral column is demonstrated in controls
(Videos S1 and S2) compared to SOD1
G93A mice in different
disease stages (preclinical stage at 60-day-old, onset of disease at 90-
day-oldand advanced clinical stage at 120-day-old mice; Videos S3,
S4, S5). Coinciding with a slowed baseline motility of microglial
processes in clinical stages (Fig. 1G), the velocity of process
extensions towards the lesion site was also significantly decreased
in these stages (105-day-old: 2.4460.18 mm/min, n=42 microglial
processes in 5 mice, p,0.001; 120-day-old: 2.1360.1 mm/min,
n=61 in 7 mice, p,0.001) compared to controls (3.0360.13 mm/
min, n=63 in 7 mice) (Fig. 2B). The latter was comparable with
lesion-induced process movements in preclinical stages and at
disease onset of SOD1
G93A (60-day-old: 3.0960.07 mm/min,
n=46 in 5 mice; 75-day-old: 2.9960.09 mm/min, n=35 in 4
mice; 90-day-old: 2.8360.17 mm/min, n=36 in 4 mice) (Fig. 2B).
Furthermore, single axon transections led to a reduced response
(increase in fluorescence located directly around the injured site) of
microglia towards the lesion site in clinical stages (105-day-old:
47.267.8%, n=5 mice, p,0.05; 120-day-old: 44.466.1%, n=6,
p,0.01) compared to control mice (set as 100614.2%, n=7)
(Fig. 2C; Videos S1, S2 and S5). At disease onset (90-day-old:
103.8616.9%, n=4), microglial response was similar to controls
(Fig. 2C). Coinciding with ameboid transformation in clinically
affected mice, SOD1
G93A microglia partly lose their directed
response towards lesioned tissue. Ameboid microglia, however,
often displayed permanent spontaneous activity with phagocytosis
of morphologically unaffected tissue (Video S6). This included
permanent ameboid migration and phagocytic activity. The rate
of spontaneous engulfments by microglial processes (13.363.9
engulfments in 250 mm6250 mm in 30 minutes, n=4 mice,
p,0.05) was significantly higher than in control mice (1.7560.25,
n=4) or preclinical SOD1
G93A mice (260.6, n=4).
Microglial reaction towards the lesion site, however, was
distinctly increased in preclinical mice (60-day-old: 179.16
16.6%, n=5 mice, p,0.01; 75-day-old: 125.563.2%, n=4;
compared to controls, set as 100614.2%, n=7) (Fig. 2C; Videos
S1, S2, S3, S4). This increased response of microglia comprised a
rapid movement of cell somata towards the lesion site (in some
cases even within a few minutes after the lesion) combined with
early phagocytic activity (Fig. 2A; Videos S3 and S4). The response
of preclinical microglia included engulfments within and around
the site of the laser-induced axonal transection.
To analyze microglial behavior at different disease stages in
clinically non-affected spinal cord tissue, another set of experi-
ments was performed within superficial layers of the dorsal
columns. These anatomic structures carry primarily ascending
fibers. Microglial response towards single axon transections within
spinal cord dorsal columns was independent of the stage of the
SOD1
G93A disease (Fig. 3; Video S7, S8, S9). Laser-induced
lesions led to similar microglial reactions in mutant and control
mice (preclinical: 89.7268.13%, n=5 mice; clinical:
97.8368.71%, n=6; compared to controls [20], set as
100614%, n=8). The comparison of control reactions in dorsal
and lateral spinal cord revealed no significant differences of
microglial reactivity within the two regions.
Neurodegeneration and neuroinflammation in the
peripheral nervous system of SOD1
G93A
Early dysfunction of lower motor neurons in SOD1
G93A mice
includes axonal deficits (e. g. accumulation of neurofilaments),
slowing of axonal transport as well as retraction and loss of
peripheral synapses at neuromuscular junctions (NMJs) long
before first clinical symptoms appear (from 40-day-old animals
onwards) [16]. This suggests an important and possibly even
primary role of the distal peripheral nervous system (PNS) in
promoting motor neuron degeneration, by e. g. retracting its
nervous terminals [16,17]. By exposing spinal roots and respective
dorsal root ganglia, time-lapse 2P-LSM imaging was applied to
analyze the role of macrophage-related neuroinflammation in
peripheral axons. Pseudounipolar neurons in dorsal root ganglia,
axons in spinal roots and surrounding macrophages were recorded
simultaneously under above mentioned in vivo conditions. Fig. 4A
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peripheral nervous system in control and in an advanced clinical
stage mouse (120-day-old). The latter contains degenerated central
descending axons and degenerated lower motor axons in the
spinal lateral column and ventral root, respectively.
During the course of the disease, lower motor axons in the
lumbar ventral roots continuously degenerated (Fig. 4B). This was
quantified by measuring signal density of EYFP-labeled axonal
structures in comparable anatomic regionsas mentioned previously.
Even inpreclinicalstages(60-day-old and75-day-old),signaldensity
was significantly lower than in control mice suggesting an early
axonal degeneration in the PNS. Signal density decreased with age
from 60-day-old to 120-day-old animals (control set as 10069.6%,
n=10 mice; 60-day-old: 69.364.9%, n=9, p,0.05; 75-day-old:
55.668.8%, n=5, p,0.05; 90-day-old: 50.5611%, n=6,
p,0.001; 105-day-old: 37.962.6%, n=6, p,0.001; 120-day-old:
29.763.4%, n=9, p,0.001) (Fig. 4C).
During the same time course, macrophages changed their
morphology forming foamy cytoplasm indicating an intracellular
accumulation of abundant lipid: a sign of phagocytosis of
degenerated myelinated tissue (Fig. 4B). Accordingly, the cellular
volume of macrophages increased indicated by an increase of the
cellular 2-dimensional area in maximum intensity projections
(MIPs) (control: 37.0262.78 mm
2, n=38 single cells in 10 mice;
60-day-old: 104.63614.46 mm
2, n=41 cells in 9 mice, p,0.05;
75-day-old: 103.58623.45 mm
2, n=20 cells in 5 mice, p,0.05;
90-day-old: 171.24624.71 mm
2, n=26 cells in 6 mice, p,0.001;
105-day-old: 212.48618.37 mm
2, n=36 cells in 6 mice, p,0.001;
120-day-old: 175.97611.98 mm
2, n=65 cells in 9 mice, p,0.001)
(Fig. 4D).
In contrast to microglia in the CNS, macrophages of control and
SOD1
G93A mice did not react towards laser-induced single axon
transections that led to acute symmetrical disintegration of ventral
root axons (Fig. 4E). Also in peripheral nerves, macrophages did not
react towards similar axon transections (data not shown). Simulta-
neous time-lapse recordings of adjacent areas of the central and
peripheral nervous system, involved in the pathophysiology of
mSOD1, show the difference in cellular activity between microglia
and macrophages (clinical stage, Video S10).
Subtle involvement of sensory axons has been described in ALS
[31,32]. To test whether neurodegeneration also takes place in
sensory roots of SOD1
G93A mice, simultaneous 2P-LSM record-
ings of ventral and dorsal lumbar roots were performed (Fig. 5A).
Interestingly, foamy transformed macrophages could also be
observed in dorsal roots of advanced clinical mice (120-day-old).
However, direct proof of axonal degeneration, e. g. axonal
interruptions, irregularities and swellings, was not found indicating
only subtle degenerative changes (Fig. 5A).
Figure 2. Microglial response in the lateral column of the spinal cord during SOD1
G93A disease course. Microglial reaction towards laser-
induced single axon transections within the lateral column of the spinal cord during SOD1
G93A disease course. A, Left images were taken 3 min after
axonal transection (autofluorescence and arrow) in control and mutant [preclinical 60-day-old, 90-day-old (onset of disease) and advanced clinical
120-day-old] mice. Images on the right were taken 60 min post lesion. See also Videos S1, S2, S3, S4, S5. B,C, Quantification of the velocity of
microglial process movements and of microglial lesion response (increase of EGFP fluorescence in a defined area around the injury) to the injured site
from preclinical stages (60-day-old and 75-day-old), onset of disease (90-day-old) to clinical and advanced clinical stages (105-day-old and 120-day-
old). Control mice were of corresponding age (60 to 140 days of age). Values are presented as mean 6 SEM; ANOVA followed by Tukey test (*p,0.05,
**p,0.01, ***p,0.001).
doi:10.1371/journal.pone.0017910.g002
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pruning of selective motor neuron axons, is assumed to be critical
in the development of motor neuron degeneration [16]. To study
distal neurodegenerative processes in SOD1
G93A mice, we
performed 2P-LSM recordings of more distal PNS regions
(Fig. 5B and 6). Simultaneous recordings of the 3 major nerves
originating from the sciatic nerve revealed different axonal
vulnerabilities (Fig. 5B). Depending on the efferent fraction, the
tibial nerve was more affected than the common peroneal nerve or
the sural nerve in clinical stages of the disease. Similar to the
neurodegeneration in ventral roots, degenerated axons were
surrounded by a high number of foamy macrophages, consistent
with previous data [33]. This observation again indicates
phagocytosis of myelinated tissue. In control nerves, only a few
macrophages, relatively small in size, were observed (Fig. 5B).
Early axonal vulnerability in motor neuron diseases is linked to
axonal transport impairment [16,34,35]. This ‘‘dying back’’
mechanism is associated with a selective vulnerability of axonal
transport leading to synaptic vesicle stalling and subsequent
synapse loss [16]. Fast-fatiguable (FF) motor axons are affected
very early (first detectable in nearly 40-day-old SOD1
G93A mice),
whereas weakening, followed by loss of fast fatigue-resistant (FR)
axons and weakening of slow (S) axons coincide with the onset of
the clinical phase and progression during advanced clinical stages
of the disease, respectively [16]. To determine clinically associated
degeneration of motor axons and their respective NMJs, musculus
tenuissimus consisting of slow twitch fibers, mainly innervated by
FR and S axons, was recorded in vivo. This muscle, provided with
retaining functions, is located proximal to the biceps femoris
muscle (therefore also known as the short head of the biceps) [36].
Fig. 6A and B show control NMJs and the adjacent vascular
network, labeled by central venous application of the dextran
conjugate Texas Red, within the muscle in 3 dimensions. Some
synapses were surrounded by thin vessels (an example is shown in
Fig. 6B). Respective motor axons of a complex of NMJs are shown
in Fig. 6C. During the course of the disease, the NMJs and their
Figure 3. Microglial response in the dorsal column of the spinal cord during SOD1
G93A disease course. Microglial reaction towards laser-
induced single axon transections within the spinal cord dorsal column (superficial layers as a sensory part, carrying primarily ascending fibers). A, Left
images were taken 3 min after axonal transection (autofluorescence and arrow) in control and mutant (preclinical 60-day-old and advanced clinical
120-day-old) mice. Respective images (right) were taken 60 min post lesion. See also Video S7, S8, S9. B, Quantification of microglial response to the
injured site. No significant differences were observed between control and mSOD1 mice. Control mice were of corresponding age (60 to 140 days of
age). Values are presented as mean 6 SEM; ANOVA followed by Tukey test.
doi:10.1371/journal.pone.0017910.g003
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began to degenerate shortly before the onset of the disease (80-
day-old) indicated by missing synapses at motor axon terminals
and by interrupted axon terminals. Around onset of disease, a
complete degeneration of some NMJ complexes was observed
(Fig. 6D). In addition, structures of broad-spectrum autofluores-
cence replaced degenerated synapses. In addition, aberrant growth
of axonal structures could be observed suggesting compensatory
attempts of motor axons to reinnervate muscle. Distinct accumu-
lations of similar autofluorescence were also observed in advanced
clinical stages (Fig. 6D). In these stages, already numerous NMJs
were degenerated.
Discussion
Microglia substantially contribute to motor neuron death and
disease progression in mSOD1 mouse models for ALS
[4,5,6,11,14,15]. Our study using the SOD1
G93A-model provides
substantial in vivo evidence that microglia-mediated inflammation
in the CNS comprises two different phases with fluent transition: i)
in preclinical stages, microglia is highly reactive as indicated by an
enhanced injury-induced response including rapid soma migration
and early phagocytic activity; ii) in clinical stages, activated
ameboid microglia lose their target-directed response, but instead
show spontaneous activity as a gain of function and a loss of its role
as highly dynamic surveillants of the CNS [19]. The increase of
microglia presence, the ameboid transformation, the loss of tissue
surveillance and the decrease of injury-directed process move-
ments, all of them mainly occurring during the clinical course,
emphasize the contribution of microglia to disease progression in
mSOD1 animals in the late phase of disease. This is consistent
with previous data [4,11].
The enhanced microglial reactivity towards focal lesions in
preclinical stages, however, supports the role of microglia as a
Figure 4. Degeneration of motor axons in spinal ventral roots during SOD1
G93A disease course. A, Reflected light overview (left side) of
the surgically exposed anatomic region. Central nervous system and proximal peripheral nervous tissue is depicted. A corresponding area, marked by
the black box, was then recorded by 2P-LSM. The vessels in the lateral column (LC) of the spinal cord could also be recognized on the 2P-LSM image
(marked by arrows). The image shows central axons and microglia of the lateral spinal cord as well as spinal root axons and spinal root macrophages.
In an advanced clinical stage (120-day-old), axonal degeneration in the LC and in the recorded ventral root (VR), indicated by interruptions and
swellings (some exemplary marked by arrows), were observed while dorsal root axons remain unaffected. B, Increase of motor axon degeneration in
the lumbar ventral roots from preclinical stages (60-day-old and 75-day-old), onset of disease (90-day-old) to clinical stages (105-day-old and 120-day-
old). During this time course, macrophages changed their morphology forming foamy cytoplasm (some exemplary cells are marked by arrows). C,D,
Quantification of axonal signal density and cellular area of macrophages during the same disease stages that were shown in B. Control mice were of
corresponding age (60 to 140 days of age). E, No morphological reaction of adjacent macrophages towards a laser-induced single axon transection
(autofluorescence in green and arrow) was observed in the ventral root of preclinical (75-day-old) mice. The transection led to an acute axonal
degeneration at both sides of the injury. Values are presented as mean 6 SEM; ANOVA followed by Tukey test (*p,0.05, **p,0.01, ***p,0.001). LC,
lateral column; DRL2-L4, dorsal root of the spinal segments L2-L4; VRL2-L3, ventral root of the spinal segments L2-L3; DRGL2, dorsal root ganglion of
the spinal segment L2.
doi:10.1371/journal.pone.0017910.g004
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injuries may represent early harmful microglial activity that
promotes axonal and neuronal degeneration. On the other hand,
rapid response to local damage leading to early clearing from
debris and neurotoxic molecules may also be beneficial and may
even attenuate ongoing focal neurodegeneration. Previous findings
by selective gene silencing [4] support the second interpretation of
our observations.
Several factors may contribute to the compromised function of
mSOD1-microglia in clinical stages such as cytoskeletal transfor-
mation towards an activated phenotype, accompanied by
alterations of transcriptional and non-transcriptional factors and
their functional consequences [23,37]. These alterations may
particularly include changes of the expression profile of receptors
and enzymes which bind signal molecules, involved in sensing
tissue abnormalities by microglia, such as ATP [18,21,38] and
Nitric oxide (NO) [20,39]. A purinergic contribution to and an
important role of NO in microglia-mediated motor neuron
degeneration has already been demonstrated [40,41,42,43]. In
particular, increase of purinergic receptors on microglia [40] and
enhanced inducible NO-synthase activity in microglia of the spinal
cord [42,43] are correlated with an increased activity of microglia.
Interestingly, earlier studies provided evidence that microglial
response to local injuries depends on ATP and NO gradients
rather than on overall ATP or NO concentration [18,20,21,38]. In
the context of chronic neurodegenerative diseases, e. g. ALS,
constantly increased ATP/NO tissue levels as a consequence of
ongoing tissue destruction would impede the rapid development of
local ATP/NO gradients. This may explain, on a molecular level,
the reduced microglial response to axonal injuries in clinical
stages. In addition, constantly high tissue levels of signal molecules
may lead to a decreased expression of respective receptors [38],
which by themselves would down-regulate the response of
microglia.
Even though the reported abnormalities in microglial behavior
could be due to an abnormally high level of mutated SOD1 per se
in the SOD1
G93A mouse, previous data analyzing mice which
overexpress the human wild-type SOD1 demonstrate that at least
the up-regulation of pro-inflammatory cytokines in microglia is
specifically due to the presence of the mutated gene [44]. Whether
the observed morphological and behavioral changes of microglia is
due to the mSOD1-protein overexpression within microglia cells
or a response to local environmental changes during the disease
course, or both is a longstanding matter of debate. Our data
analyzing SOD1
G93A microglia reaction in the non-affected part
of the spinal dorsal columns carrying primarily ascending fibers,
strongly suggest that environmental changes are at least a
prerequisite for microglia-mediated neuroinflammation. The
unaltered microglial morphology and reaction to axonal injury
throughout the course of the disease in a sensory part of the spinal
cord emphasizes a secondary role of microglia-mediated neuroin-
flammation in the pathophysiology of mSOD1. Furthermore, the
finding that mutant microglia show no aberrant inflammatory
behavior in non-affected spinal tissue supports the non-cell-
autonomous pathophysiology of mSOD1.
The process of microglial transformation is accompanied by
changes of the cellular expression profile. This leads to an increase
of cytokine and radical release [23] which, by itself, promotes
further neuroinflammatory activity also in other cell types, e. g.
astrocytes. In this context, even extracellularly located mSOD1
proteins sustain or trigger the ongoing neuroinflammation [45,46].
However, our data do not distinguish between an aberrant
behavior of microglia due to the mutant SOD1 expression or to an
activated state of microglia as response to chronic environmental
changes.
Furthermore, we observed spontaneous formation of cell
clusters in mSOD1 mice. This has not been described in WT or
control animals in a number of recent studies including in vivo
imaging approaches [18,19,20,21,23]. This observation indicates
that a crucial role of microglia which is permanent tissue
surveillance, is impaired in mSOD1 animals. In support of this,
a recent study shows formation of multinucleated giant cells
through fusion of microglial cells in the spinal cord of clinically
affected mSOD1 mice [47]. On a cellular level microglia undergo,
at least in part, structural abnormalities during the course of
mSOD1 disease which are indicative of cellular degeneration [47].
Recent data show that only a low number of CST fibers are
found in the lateral white matter (lateral CST fibers are mostly
Figure 5. Degeneration of peripheral nerves during the disease course in SOD1
G93A mice. A, Exemplary simultaneous 2P-LSM recordings
of axons and macrophages in ventral and dorsal lumbar roots in wild-type and advanced clinical (120-day-old) mice. Degeneration of motor axons in
the ventral root and increase of the cellular volume of macrophages in the ventral and dorsal roots were observed in the mutant mouse. B, Distinct
degeneration of peripheral axons in a 120-day-old SOD1
G93A mouse (clinical stage), shown by simultaneous recording of the 3 major nerves
originating from the sciatic nerve. The tibial nerve was more affected than the common peroneal nerve or the sural nerve. Degenerated axons were
abundantly surrounded by foamy macrophages. The imaged region is indicated in the insert (CCD camera image). Note that EYFP fluorescence is
depicted with a red color table. DRL2, dorsal root of the spinal segment L2; VRL3, ventral root of the spinal segment L3.
doi:10.1371/journal.pone.0017910.g005
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the diameter of CST fibers is relatively small (even if a population
of larger fibers was found in the lateral CST, more than 90% of
the CST fibers were less than 1.5 mm in diameter) [48]. Therefore,
the high rate of the observed degeneration of apparently relatively
large axons in lateral spinal cord suggests ongoing neurodegen-
eration within this part of the spinal cord white matter that
includes more fiber tracts than the pyramidal tracts. Whether
additional degeneration of the extrapyramidal system plays a role
in the pathophysiology of mSOD1 needs further investigation.
Interestingly, extrapyramidal involvement seems to play a role in
stiffness and balance impairment in a subset of ALS patients [49].
Different to microglia-mediated neuroinflammation in the CNS,
macrophages do not respond to focal injuries in the PNS. Early
involvement of macrophages includes transformation to ‘foamy’
macrophages which indicates a passive role of clearing debris,
particularly lipid-rich myelin. This is in line with previous findings
showing changes in the expression profile of myelin-laden
macrophages towards a dominance of anti-inflammatory proteins
[50]. Nonetheless, the functional consequence of the apparently
contradictory up-regulation of the activity marker CD11b in
peripheral macrophages during mSOD1 disease course, recently
shown by immunohistochemical analysis [51], has to be elucidated.
An activeroleof macrophagesinchronic axonal neurodegeneration
by, for instance, the release of toxic radicals or cytokines can not be
excluded andremainsto beclarified.However, otherdata,obtained
by characterization of macrophage activation during disease
progression, also suggest phagocytic removal of debris as the
primary role of macrophages in the PNS emphasizing their non-
detrimental function [33]. These findings are indications of a
primarily neurodegenerative process in the PNS without substantial
inflammatory contributions. They even suggest a rather pro-
regenerative role of activated macrophages. The data strengthen
the idea of distinct inflammatory activities in the CNS versus PNS,
one with a dominant neuroinflammatory response in the CNS and
another with primarily degenerative processes in the PNS.
Several studies suggested that axonal degeneration in the PNS
including early loss of NMJs is a primary pathophysiological event
Figure 6. Degeneration of neuromuscular junctions (NMJs) during SOD1
G93A disease course in a muscle innervated by slow-motor
neurons. Exemplary motor axons and NMJs of musculus tenuissimus (containing mainly slow twitch fibers) were imaged in control and SOD1
G93A
(mSOD1) mice. EYFP fluorescence is depicted with a green color table. The vascular network, labeled by central venous application of the dextran
Texas Red, is depicted with a red color table. A,B, Control NMJs and the adjacent vascular network are shown in 3 dimensions (in A the same region
from 4 different perspectives is depicted). The inserts in B are a maximum intensity projection (MIP, upper insert) and an epifluorescence image
(lower insert) of the two NMJs. C, Respective motor axons of a complex of NMJs in a control mouse. Two adjacent NMJs of different morphology are
shown in the insert. D, Degeneration of NMJs and their respective motor axons during the course of SOD1
G93A disease in musculus tenuissimus. 60-
day-old: morphologically unchanged NMJs when compared to controls; two intact synapses are shown in the inserts. 80-day-old: degenerated
(arrowhead) or missing synapses (arrow) at the end of some motor axons; interrupted axon terminals (arrowheads) are shown in the insert. 100-day-
old: advanced degeneration of the recorded axon complexes (including the inserts), indicated by missing synapses (arrowhead on the right side of
the overview and arrowheads in the right insert), structures of broad-spectrum fluorescence (arrowhead on the left side of the overview and
arrowheads in the left insert) and aberrant growth of axons. 120-day-old: interruption of a motor axon (arrowheads) and structures of broad-
spectrum fluorescence (arrow, arrowhead in the insert). Note that musculus tenuissimus is innervated mainly by slow-motor neurons. These motor
neurons show signs of NMJ denervation in SOD1
G93A mice at approximately onset of disease. Scale bars, 20 mm; inserts, 10 mm.
doi:10.1371/journal.pone.0017910.g006
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tions have revealed that axonal loss in lumbar ventral roots in
preclinical stages occurs earlier than cell body loss in the ventral
horn of the spinal cord [55]. Dysfunction of distal parts of the
motor neuron apparently precedes the onset of disease. Our data
analyzing axonal degeneration in the PNS supports this hypothesis
by showing axonal loss in ventral roots of the lumbar spine as early
as from day 60 onwards. However, neither can we, based on the
presented in vivo data, strictly confirm a ‘dying back’ mechanism
nor a ‘distal axonopathy’. Loss of neuromuscular junctions appears
strongly dependent on the type of muscle [16,52]. In muscles
mainly innervated by fast-fatigue-resistant and slow-motor neu-
rons, such as the musculus tenuissimus, pruning of motor axons
and the respective NMJs begins at symptom onset. In muscles
mainly innervated by fast-fatigable motor neurons, loss of NMJs is
already observed in presymptomatic stages.
Selective motor neuron degeneration arises from the conver-
gence of a series of pathophysiological factors [5,56,57,58].
Neuroinflammation apparently goes along with neurodegenerative
processes. Using an in vivo imaging approach that allows us to
visualize cell-cell interaction over a time course of hours, we
present evidence for distinct mSOD1-induced inflammatory
activities in the CNS versus the PNS. We suggest that microglia-
mediated neuroinflammation in the CNS promotes neurodegen-
eration in clinical stages of the disease while cellular changes of
macrophages in the PNS support a passive role. Neurodegener-
ation with axonal degeneration and loss of NMJs, considered a
primary event in ALS pathogenesis, may underlay the hitherto
limited response of animal models or human trials to anti-
inflammatory therapies.
Supporting Information
Video S1 Microglial reaction towards single axon
transection in the spinal cord lateral column of control
mice. The experiments were performed in double transgenic
mice expressing EGFP in microglia and EYFP in projection
neurons. Microglia are depicted in green while, for better
visualization and distinction, axons are shown in red. All videos
are arranged such that rostral is to the left side. This video
sequence (105 minutes length) lasts from 45 minutes before to 60
minutes after a laser-induced axonal transection (the injury was set
at 0 min). It shows microglial reaction towards the site of the injury
(note the autofluorescence as speckles in the image center; marked
by arrow). Surrounding microglia immediately extended their
processes forming a shielding ring around the injury. The
transection led to an acute axonal degeneration at both sides of
the injury, indicated by interruptions and bulb-like swellings.
Within the recorded time-lapse sequence of 60 minutes after
injury, reacting microglial cells polarized and began to migrate in
an ameboid manner towards the injured axon. No phagocytic
activity of microglia was observed within the first hour after the
injury. Note the monocytes within the blood vessels. The control
mouse was 90 days of age. The video sequence corresponds to a
time-lapse series of 53 stacks of images. Each of these stacks is
shown as a maximum intensity projection (MIP). The frame rate of
the video is about 2 minutes per MIP. Scale bar, 20 mm.
(MOV)
Video S2 Detailed microglial reaction towards single
axon transection in the spinal cord lateral column of
control mice. This video sequence (75-minute) lasts from 15
minutes before to 60 minutes after a laser-induced axonal
transection. It shows microglial reaction towards the injured site
(note the autofluorescence; arrow) and the acute axonal degener-
ation in more detail when compared with video S1. The control
mouse was 120 days of age. The frame rate of the video is 65
seconds per MIP. Scale bar, 20 mm.
(MOV)
Video S3 Enhanced response and early migration of
microglia towards a single axon transection in the
lateral column of a preclinical SOD1
G93A mouse. This
video sequence (195-minute) lasts from 15 minutes before to 180
minutes after a laser-induced axonal transection in a 60-day-old
mutant mouse. It shows an increased response of microglia
towards the injured site (note the autofluorescence; arrow). The
response comprised a rapid movement of cell soma starting within
a few minutes after the injury. An enhanced and early (starting
within the first hour after the injury) phagocytic activity of
microglia, indicated by numerous engulfments within and around
the injured site, could also be observed. The frame rate of the
video is about 90 seconds per MIP. Scale bar, 20 mm.
(MOV)
Video S4 Early phagocytosis after a single axon tran-
section in the lateral column of a preclinical SOD1
G93A
mouse. This video sequence (90-minute) lasts from 15 minutes
before to 75 minutes after an axonal transection in a 75-day-old
mutant mouse. It shows, similar to the Video S3, an increased
response of microglia towards the injured site (note the
autofluorescence in the image center; arrow). The response
comprised an early phagocytic activity of microglia at both sides
of the injury. Note the engulfment and the subsequent phagocy-
tosis of an EYFP-containing bulb-like swelling of the transected
degenerating axon about 30 mm to the right to the injured site
(arrow). The frame rate of the video is 85 seconds per MIP. Scale
bar, 20 mm.
(MOV)
Video S5 Lack of microglial reaction after single axon
transection in the lateral column of a clinical SOD1
G93A
mouse. This video sequence (145-minute) lasts from 25 minutes
before to 120 minutes after an axonal transection in a 120-day-old
mutant mouse. It shows a highly reduced microglial reaction
towards the tissue lesion (note the autofluorescence in the image
center; arrow). The axonal transection led to degeneration of the
axon at both sides of the injury without any apparent contribution
of microglia. Note the increased microglial activity including
numerous engulfments and continuous ameboid migration
independent of the injury setting. The frame rate of the video is
115 seconds per MIP. Scale bar, 20 mm.
(MOV)
Video S6 Spontaneous activity of microglia in the
lateral column of a clinical SOD1
G93A mouse. This video
sequence (60-minute) shows enhanced spontaneous activity of
ameboid microglia in a 120-day-old mutant mouse. This activity
included permanent ameboid migration (arrows) and permanent
phagocytic processes. The frame rate of the video is 128 seconds
per MIP. Scale bar, 20 mm.
(MOV)
Video S7 Microglial reaction towards a single axon
transection in the spinal dorsal column of a control
mouse. This video sequence (80-minute) lasts from 7 minutes
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shows microglial reaction towards the site of the injury (note the
autofluorescence; arrow). Surrounding microglia immediately
extended their processes forming a shielding ring around the
injury. The transection led to an acute axonal degeneration at
both sides of the injury. Note the monocytes within the blood
vessels. The control mouse was 90 days of age. The frame rate of
the video is 80 seconds per MIP. Scale bar, 20 mm.
(MOV)
Video S8 Microglial reaction towards a single axon
transection in the spinal cord dorsal column of a
preclinical SOD1
G93A mouse. This video sequence (80-
minute) lasts from 20 minutes before to 60 minutes after an
axonal transection in a 60-day-old mutant mouse. It shows, similar
to the control mouse (Video S7), microglial reaction towards the
site of the injury (note the autofluorescence; arrow). The frame
rate of the video is about 1 minute per MIP. Scale bar, 20 mm.
(MOV)
Video S9 Microglial reaction towards a single axon
transection in the spinal cord dorsal column of a clinical
SOD1
G93A mouse. This video sequence (64-minute) lasts from 4
minutes before to 60 minutes after an axonal transection in a 120-
day-old mutant mouse. It shows, similar to the Video S7 and S8,
microglial reactions towards the site of the injury (note the
autofluorescence; arrow). Note the monocytes within the blood
vessel on the left side. The frame rate of the video is 116 seconds
per MIP. Scale bar, 20 mm.
(MOV)
Video S10 Simultaneous recording of microglia and
macrophages in a clinical SOD1
G93A mouse. This video
sequence (45-minute) shows spontaneous microglial activity and
cluster formation in the lateral column of the spinal cord (upper
part) compared to minimal morphological movements of macro-
phages in an adjacent ventral root (lower part) in a 105-day-old
mutant mouse. The frame rate of the video is about 73 seconds per
MIP. Scale bar, 20 mm.
(MOV)
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